Zhenxiang Li

2.1k total citations
72 papers, 962 citations indexed

About

Zhenxiang Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zhenxiang Li has authored 72 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Zhenxiang Li's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (14 papers) and Peptidase Inhibition and Analysis (9 papers). Zhenxiang Li is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (14 papers) and Peptidase Inhibition and Analysis (9 papers). Zhenxiang Li collaborates with scholars based in China, United Kingdom and Sweden. Zhenxiang Li's co-authors include Haiyong Wang, Jiamao Lin, Jinming Yu, Fen Zhao, Chenyue Zhang, Chenxing Zhang, Jianbo Zhang, Qingliang Wang, Minghuan Li and Jianbin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Zhenxiang Li

68 papers receiving 956 citations

Peers

Zhenxiang Li
Qingfang Li China
Zhibo Zhang China
Federica Biello Italy
Ran Zhong China
Mihaela Aldea France
Takeo Fujii United States
Xiuyi Zhi China
Xiuyun Tian China
Qingfang Li China
Zhenxiang Li
Citations per year, relative to Zhenxiang Li Zhenxiang Li (= 1×) peers Qingfang Li

Countries citing papers authored by Zhenxiang Li

Since Specialization
Citations

This map shows the geographic impact of Zhenxiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenxiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenxiang Li more than expected).

Fields of papers citing papers by Zhenxiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenxiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenxiang Li. The network helps show where Zhenxiang Li may publish in the future.

Co-authorship network of co-authors of Zhenxiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenxiang Li. A scholar is included among the top collaborators of Zhenxiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenxiang Li. Zhenxiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Hongbin, Jiawei Zhu, Xiaomeng Zhao, et al.. (2025). OmniDocBench: Benchmarking Diverse PDF Document Parsing with Comprehensive Annotations. 24838–24848.
2.
Zhu, Kunli, Jing Fan, Changchun Zhou, et al.. (2025). The highly expressed GOLPH3 in colorectal cancer cells activates smoothened to drive glycolysis and promote cancer cell growth and radiotherapy resistance. Journal of Gastrointestinal Oncology. 16(2). 415–434.
3.
Lin, Tong, et al.. (2024). Preparation of ZIF-67 derived Co3O4 composite non-homogeneous catalysts with cerium oxide for the efficient degradation of Rhodamine B. Inorganic Chemistry Communications. 170. 113132–113132. 1 indexed citations
4.
Li, Zhenxiang, et al.. (2024). Fabrication of CeO2/CaO nanocomposite as ultraviolet screening agent and its application in sunscreen. Ceramics International. 50(11). 20431–20440. 11 indexed citations
5.
Li, Zhenxiang, Da Wang, Fang‐Hua Liu, et al.. (2024). Plant Volatile Methyl Salicylate Primes Wheat Defense Against the Grain Aphid by Altering the Synthesis of Defense Metabolites. Plant Cell & Environment. 6 indexed citations
6.
Lin, Tong, et al.. (2024). Synthesis of CeO2-loaded composite catalysts of ZIF-67 for activation of persulfate degradation of Congo red dye. Colloids and Surfaces A Physicochemical and Engineering Aspects. 685. 133189–133189. 12 indexed citations
7.
Wu, Qibin, et al.. (2024). LC05-136 originates from ROC22, green arising from blue and surpassing blue. 3(1). 0–0. 4 indexed citations
8.
Li, Zhenxiang, et al.. (2024). Fault Diagnosis Method for Space Fluid Loop Systems Based on Improved Evidence Theory. Entropy. 26(5). 427–427. 1 indexed citations
9.
Zhang, Chenyue, Kai Wang, Wenjie Liu, et al.. (2022). Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma. Frontiers in Oncology. 12. 1054845–1054845. 1 indexed citations
10.
Li, Zhenxiang, Qing Zhou, Qi Wang, Haiyong Wang, & Weiming Yue. (2022). EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers. BMC Pulmonary Medicine. 22(1). 356–356. 1 indexed citations
11.
Wang, Qi, et al.. (2022). Immunomodulatory role of metalloproteases in cancers: Current progress and future trends. Frontiers in Immunology. 13. 1064033–1064033. 27 indexed citations
12.
Zhang, Chenyue, Zhenxiang Li, Yanxiang Zhang, et al.. (2022). Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma. International Journal of General Medicine. Volume 15. 4209–4220. 8 indexed citations
13.
Shang, Xiaoling, et al.. (2021). Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab. Lung Cancer. 154. 105–112. 19 indexed citations
14.
Shang, Xiaoling, Jia Li, Hui Wang, et al.. (2020). CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma. International Immunopharmacology. 88. 106864–106864. 16 indexed citations
15.
Shi, Jing-Zhen, Yingjie Zhang, Jinzhi Wang, Jianbin Li, & Zhenxiang Li. (2020). Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 10. 995–995. 21 indexed citations
16.
17.
18.
Wang, Zhijie, Zhenxiang Li, Zhirong Shen, et al.. (2015). ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations. Scientific Reports. 5(1). 11392–11392. 18 indexed citations
19.
Li, Zhenxiang. (2005). Grid Computing and Its Application. Computer and Modernization. 1 indexed citations
20.
Jin, Ying‐Tai, et al.. (1989). SYNTHESIS AND CRYSTAL STRUCTURE OF BIMETALLIC YTTRIUM COMPLEX. Chinese Journal of Applied Chemistry. 6(6). 67–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingfang Li Breakdown of academic impact, for papers by Zhibo Zhang Breakdown of academic impact, for papers by Federica Biello Breakdown of academic impact, for papers by Ran Zhong Breakdown of academic impact, for papers by Mihaela Aldea Breakdown of academic impact, for papers by Takeo Fujii Breakdown of academic impact, for papers by Xiuyi Zhi Breakdown of academic impact, for papers by Xiuyun Tian
Rankless by CCL
2026